Design Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	181	148	574	1,192	-	-
Market Cap Growth	-29.47%	-74.13%	-51.87%	-	-	-
Enterprise Value	-88	-131	246	811	-36	1
PE Ratio	-	-2.22	-9.06	-33.54	-	-
PB Ratio	0.67	0.53	1.75	3.12	-	-
P/FCF Ratio	-4.22	-2.52	-10.99	-38.55	-	-
P/OCF Ratio	-4.25	-2.53	-11.18	-40.57	-	-
EV/Sales Ratio	-	-	-	-	-159.69	0.74
EV/EBITDA Ratio	0.70	1.98	-3.92	-22.91	4.36	-0.30
EV/EBIT Ratio	0.70	1.96	-3.89	-22.82	4.36	-0.30
EV/FCF Ratio	0.76	2.23	-4.72	-26.23	4.13	-4.45
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-	-0.19
Debt / EBITDA Ratio	-0.04	-0.04	-0.05	-0.09	-	-0.34
Debt / FCF Ratio	-0.04	-0.04	-0.06	-0.10	-	-5.00
Quick Ratio	38.16	29.29	30.66	72.70	15.49	0.02
Current Ratio	38.61	29.58	31.10	72.96	15.55	0.02
Asset Turnover	0	0	0	0	0.01	-
Return on Equity (ROE)	-20.80%	-22.80%	-18.10%	-9.00%	110.70%	-
Return on Assets (ROA)	-19.90%	-21.80%	-17.60%	-8.80%	-45.20%	-
Return on Capital (ROIC)	-26.11%	-27.92%	-20.46%	-9.30%	73.62%	64.74%
Earnings Yield	-32.45%	-45.05%	-11.04%	-2.98%	-	-
FCF Yield	-29.84%	-39.63%	-9.10%	-2.59%	-	-
Buyback Yield / Dilution	-1.04%	-0.50%	-21.27%	-190.80%	-2.08%	-
Total Shareholder Return	-1.04%	-0.50%	-21.27%	-190.80%	-2.08%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).